Brii Biosciences Ltd (HKSE:02137)
HK$ 1.09 0 (0%) Market Cap: 795.53 Mil Enterprise Value: -2.06 Bil PE Ratio: 0 PB Ratio: 0.23 GF Score: 19/100

Brii Biosciences Ltd Business Update Call: HIV Ph 1 Study Status Transcript

Dec 14, 2021 / 12:30PM GMT
Release Date Price: HK$36.95 (-0.14%)
Operator

Good day and thank you for standing by. Welcome to Brii Biosciences. This is Update Call HIV Phase 1 Study Status. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) And now, I like to hand the conference over to Ms. Chris Fang, Investor Relations Director all Brii Biosciences. Thank you, please go ahead.

Chris Fang
Brii Biosciences - Investor Relations Director

Yes, thank you, operator. And good day, ladies and gentlemen who join the Brii Bio for HIV update call. So, for joining me today's call, we have our Dr. David Margolis, which is our Vice President, Head of Infectious Disease TA. And also we have our CFO and Joint Company Secretary, Dr. Ankang Li.

We noticed that recently, a lot of that are if not related trial. So we're going to welcome David to have a brief introduction. And then we open the Q&A session. Thank you. David, please go ahead.

David Margolis
Brii Biosciences - CFO

Yes, thank you. And hi, everyone. I appreciate you joining.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot